Detection of auto-antibodies in the serum and blister fluid in patients diagnosed with Bullous Pemphigoid
Not Applicable
- Conditions
- Health Condition 1: L120- Bullous pemphigoid
- Registration Number
- CTRI/2020/06/025985
- Lead Sponsor
- K Mahadevan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All new cases of bullous pemphigoid diagnosed by clinical examination, histopathology & by direct immunofluorescence
Patients in active disease can be categorized as:Active new bullous lesions
Exclusion Criteria
Patients in clinical remission & Other bullous disorders are also excluded.
Bullous pemphigoid patients without tense bullae
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Detection of BP180 and BP230 antibodies in the blister fluid of bullous pemphigoid patientsTimepoint: at baseline-one time
- Secondary Outcome Measures
Name Time Method Blister fluid can be used as an alternative for blood in detecting BP180 and BP230 auto-antibodies with ELISA, especially in old age patients.Timepoint: at baseline